Breaking News

HHS Funds Development of Needle-free Vax Technology

Patch could administer vaccines without traditional needles reducing the need for refrigeration in transport and storage, and possibly self-administration.

By: Contract Pharma

Contract Pharma Staff

The U.S. Department of Health and Human Services (HHS) is supporting the development of a patch could administer vaccines without traditional needles. Under an approximately $22 million, 3-year agreement between the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS, and Vaxxas, the company will conduct U.S. and Australian Phase I trials to evaluate the safety and efficacy of an easy-to-use, high-density micro-array patch (HD-MAP) and other development activities for...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters